Literature DB >> 543875

Synthesis and anti-inflammatory properties of budesonide, a new non-halogenated glucocorticoid with high local activity.

A Thalén, R Brattsand.   

Abstract

As part of a study of the local anti-inflammatory activity of corticosteroid 16 alpha, 17 alpha-acetals it was found that on acetalization of 16 alpha-hydroxyprednisolone with n-butyraldehyde the two possible epimers were formed in the ratio of 1: 1. The reaction product was resolved by column chromatography on Sephadex LH-20. The isolated epimers were studied by NMR and mass spectrometry. The epimeric mixture of this new non-halogenated corticoid, 16 alpha, 17 alpha-(22R,S)-propylmethylenedioxypregna-1,4-diene-11 beta,21-diol-3,20-dione (budesonide), was shown to have a local antiinflammatory potency comparable to that of fluocinolone acetonide in cotton pellet tests in rats. In contrast, its systemic glucocorticoid activity was found to be 4--7 times lower than that of fluocinolone acetonide, however.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 543875

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  8 in total

1.  [Treatment of autoimmune liver diseases. Autoimmune hepatitis and primary sclerosing cholangitis].

Authors:  C P Strassburg; M P Manns
Journal:  Internist (Berl)       Date:  2011-12       Impact factor: 0.743

2.  The influence of a new corticosteroid, budesonide, on anaphylactic bronchoconstriction and SRS-A release in the guinea pig.

Authors:  K Forsberg; L Sörenby
Journal:  Agents Actions       Date:  1981-07

3.  Protective effects of the glucocorticoid, budesonide, on lung anaphylaxis in actively sensitized guinea-pigs: inhibition of IgE-but not of IgG-mediated anaphylaxis.

Authors:  P Andersson; R Brattsand
Journal:  Br J Pharmacol       Date:  1982-05       Impact factor: 8.739

4.  Pharmacokinetics of budesonide in children with asthma.

Authors:  S Pedersen; G Steffensen; I Ekman; M Tönnesson; O Borgå
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

5.  Acute dose-response studies in bronchial asthma with a new corticosteroid, budesonide.

Authors:  R Ellul-Micallef; S A Johansson
Journal:  Br J Clin Pharmacol       Date:  1983-04       Impact factor: 4.335

6.  Topical and systemic glucocorticoid potencies of budesonide and beclomethasone dipropionate in man.

Authors:  S A Johansson; K E Andersson; R Brattsand; E Gruvstad; P Hedner
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 7.  Budesonide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in asthma and rhinitis.

Authors:  S P Clissold; R C Heel
Journal:  Drugs       Date:  1984-12       Impact factor: 9.546

Review 8.  Epidemiology and treatment of autoimmune hepatitis.

Authors:  Sven Francque; Luisa Vonghia; Albert Ramon; Peter Michielsen
Journal:  Hepat Med       Date:  2012-03-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.